Equisetum sylvaticum base reduces atherosclerosis risk factors in rats fed a high-fat diet

Authors

  • Cheng-He Lin Department of Nuclear Medicine, The First Affiliated Hospital of Jilin University, Changchun
  • Hua-Li Xu School of Pharmacy of Jilin University, Changchun
  • Wei-Lun Sun School of Pharmacy of Jilin University, Changchun
  • Feng Li Department of Nuclear Medicine, The First Affiliated Hospital of Jilin University, Changchun
  • Guang-Zhu Lin The First Affiliated Hospital of Jilin University

DOI:

https://doi.org/10.3329/bjp.v9i3.18593

Keywords:

Equisetum sylvaticum, Hyperlipidemia, SOD

Abstract

We identify an Equisetum sylvaticum alkaloid (ESA) derived from E. hyemale, which has robust antihyperlipidemic effects in rats fed a high-fat diet. ESA was isolated from E. hyemale and identified by IR, 13C NMR and 1H NMR. Rats were induced to hyperlipidemia and subjected to ESA treatment. In hyperlipidemic model, fed with a high-fat diet, the blood levels of TC, TG and LDL-C were increased. The administration of ESA (20 or 40 mg/kg) to those rats significantly improved the HDL-C level and reduced the levels of TC, TG, LDL-C. The atherosclerosis index and atherosclerosis risk of these rats were significantly reduced by ESA. In addition, the administration of ESA in rats increased the activity of SOD and decreased the level of MDA. These results reveal the antihyperlipidemic and anti-oxidative effects of ESA in vivo.

Downloads

Download data is not yet available.
Abstract
1647
Download
689 Read
172

References

Asdonk T, Motz I, Werner N, Coch C, Barchet W, Hartmann G, Nickenig G, Zimmer S. Endothelial RIG-I activation impairs endothelial function. Biochem Biophys Res Commun. 2012; 420: 66-71.

Ding Z, Liu S, Wang X, Khaidakov M, Dai Y, Mehta JL. Oxidant stress in mitochondrial DNA damage, autophagy and inflammation in atherosclerosis. Sci Rep. 2013; 3: 1077.

Dobiasova M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: Correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem. 2001; 34: 583-88.

Filippatos TD. A review of time courses and predictors of lipid changes with fenofibric acid-statin combination. Cardiovasc Drugs Ther. 2012; 26: 245-55.

Haas MJ, Mooradian AD. Inflammation, high-density lipoprotein and cardiovascular dysfunction. Curr Opin Infect Dis. 2011; 24: 265-72.

Hadi NR, Yousif NG, Abdulzahra MS, Mohammad BI, Al-Amran FG, Majeed ML, Yousif MG. Role of NF-kappabeta and oxidative pathways in atherosclerosis: Cross-talk between dyslipidemia and Candesartan. Cardiovasc Ther. 2013; 31: 381-87.

Kitamura A, Noda H, Nakamura M, Kiyama M, Okada T, Imano H, Ohira T, Sato S, Yamagishi K, Iso H. Association between non-high-density lipoprotein cholesterol levels and the incidence of coronary heart disease among Japanese: The Circulatory Risk in Communities Study (CIRCS). J Atheroscler Thromb. 2011; 18: 454-63.

Li H, Wang P, Liu Q, Cheng X, Zhou Y, Xiao Y. Cell cycle arrest and cell apoptosis induced by Equisetum hyemale extract in murine leukemia L1210 cells. J Ethnopharmacol. 2012; 144: 322-27.

Mani S, Li H, Untereiner A, Wu L, Yang G, Austin RC, Dickhout JG, Lhoták Š, Meng QH, Wang R. Decreased endogenous production of hydrogen sulfide accelerates atherosclerosis. Circulation 2013; 127: 2523-34.

McCrindle BW, Urbina EM, Dennison BA, Jacobson MS, Steinberger J, Rocchini AP, Hayman LL, Daniels SR. Drug therapy of high-risk lipid abnormalities in children and adolescents: A scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. Circulation 2007; 115: 1948-67.

Mohania D, Kansal VK, Shah D, Nagpal R, Kumar M, Gautam SK, Singh B, Behare PV. Therapeutic effect of probiotic dahi on plasma, aortic, and hepatic lipid profile of hypercholesterolemic rats. J Cardiovasc Pharmacol Ther. 2013; 18: 490-97.

Singh P, Mann KA, Mangat HK, Kaur G. Prolonged glutamate excitotoxicity: Effects on mitochondrial anti-oxidants and anti-oxidant enzymes. Mol Cell Biochem. 2003; 243: 139-45.

Tobert JA. Lovastatin and beyond: The history of the HMG-CoA reductase inhibitors. Nat Rev Drug Discov. 2003; 2: 517-26.

Vaidya AD, Vaidya R. Reactive oxygen species, anti-oxidant enzymes and smoldering chronic inflammation: Relevance to diabetes mellitus, atherosclerosis, and menopausal metabolic syndrome. J Midlife Health. 2011; 2: 49-50.

Vijayakumar RS, Surya D, Nalini N. Anti-oxidant efficacy of black pepper (Piper nigrum L.) and piperine in rats with high-fat diet induced oxidative stress. Redox Rep. 2004; 9: 105-10.

Wu WY, Wang YP. Pharmacological actions and therapeutic applications of Salvia miltiorrhiza depside salt and its active components. Acta Pharmacol Sin. 2012; 33: 1119-30.

Xu CF, Bian XY, Qu SM, You LH, Qi ZM, Cheng W, Liu XJ, Liu WZ, Ren SJ. [Effect of Equisetum hyemale on experimental hyperlipemia in rats and its toxic test]. Zhongguo Zhong Yao Za Zhi. 1993; 18: 52-53.

Yancey PG, Bortnick AE, Kellner-Weibel G, de la Llera-Moya M, Phillips MC, Rothblat GH. Importance of different pathways of cellular cholesterol efflux. Arterioscler Thromb Vasc Biol. 2003; 23: 712-19.

Zelko IN, Mariani TJ, Folz RJ. Superoxide dismutase multigene family: A comparison of the CuZn-SOD (SOD1), Mn-SOD (SOD2), and EC-SOD (SOD3) gene structures, evolution, and expression. Free Radic Biol Med. 2002; 33: 337-49.

Zeng Y, Song JX, Shen XC. Herbal remedies supply a novel prospect for the treatment of atherosclerosis: A review of current mechanism studies. Phytother Res. 2012; 26: 159-67.

Published

2014-07-02

How to Cite

Lin, C.-H., H.-L. Xu, W.-L. Sun, F. Li, and G.-Z. Lin. “Equisetum Sylvaticum Base Reduces Atherosclerosis Risk Factors in Rats Fed a High-Fat Diet”. Bangladesh Journal of Pharmacology, vol. 9, no. 3, July 2014, pp. 257-61, doi:10.3329/bjp.v9i3.18593.

Issue

Section

Research Articles